| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| AA332074 | Embryo, 8 weeks | .l | 263 to 536 | 1 to 274 | tiling clone, | 274/274 (100 %) | 0 diff (100 %id) | ||
| AA383173 | testis | .b | 3484 to 3764 | 1 to 281 | 281/281 (100 %) | 2 diff (99.3 %id) | |||
| AF040247 | Liver | .b | 1730 to 2069 | 1 to 339 | 339/339 (100 %) | 8 diff (97.7 %id) | |||
| AK025270 | colon | .h | 1 to 1097 | 1 to 1097 | exact | tiling clone, available from FLJ, AAA | 1097/1097 (100 %) | 1 diff (100.0 %id) | |
| AK091507 | brain | .b | 134 to 3663 | 1 to 3530 | tiling clone, available from FLJ, | 3530/3530 (100 %) | 1 diff (100.0 %id) | ||
| AK314958 | .b | 2110 to 3853 | 1 to 1744 | 1744/1744 (100 %) | 0 diff (100 %id) | ||||
| AL050102 | uterus | .b | 2368 to 4524 | 1 to 2157 | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 2157/2157 (100 %) | 1 diff (100.0 %id) | |
| AW361021 | colon | .b | 3908 to 4300 | 3 to 395 | 393/395 (99 %) | 7 diff (98.3 %id) | |||
| AW977809 | .j | 2085 to 2531 | 448 to 1 | Submitted on the opposite strand | 448/451 (99 %) | 12 diff (97.4 %id) | |||
| AX747027 | .b | 134 to 3663 | 1 to 3530 | 3530/3530 (100 %) | 1 diff (100.0 %id) | ||||
| BC026172 | testis | .e | 347 to 4184 | 403 to 4240 | E522G | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 4240/4240 (100 %) | 3 diff (100.0 %id) |
| BC107479 | PCR rescued clones | .a | 1 to 4128 | 1 to 4128 | exact | tiling clone, | 4128/4128 (100 %) | 2 diff (100.0 %id) | |
| BE089155 | breast | .b | 3767 to 4013 | 1 to 246 | 246/247 (99 %) | 9 diff (96.4 %id) | |||
| BF733748 | amnion_normal | .b | 2165 to 2429 | 287 to 24 | Submitted on the opposite strand | 264/326 (80 %) | 5 diff (98.5 %id) | ||
| BF736797 | bladder_tumor | .p-u | 184 to 555 | 381 to 6 | Submitted on the opposite strand | 376/385 (97 %) | 0 diff (100 %id) | ||
| BF748959 | breast_normal | .b | 3929 to 4181 | 12 to 265 | 254/280 (90 %) | 13 diff (95.4 %id) | |||
| BF986168 | placenta_normal | .b | 3288 to 3635 | 1 to 348 | 348/348 (100 %) | 20 diff (94.3 %id) | |||
| BG990611 | head_neck | .j | 211 to 584 | 1 to 399 | tiling clone, | 399/399 (100 %) | 28 diff (93.0 %id) | ||
| BQ694700 | adipose | .b | 3781 to 4519 | 1 to 739 | 739/739 (100 %) | 7 diff (99.1 %id) | |||
| DA103670 | cerebellum | .b | 162 to 704 | 2 to 544 | capped | 543/543 (100 %) | 0 diff (100 %id) | ||
| DA105078 | cerebellum | .b | 132 to 693 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
| DA113604 | cerebellum | .b | 142 to 697 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
| DA113898 | cerebellum | .b | 1341 to 1924 | 2 to 585 | capped | 584/584 (100 %) | 1 diff (99.9 %id) | ||
| DA142836 | alzheimer cortex | .b | 2875 to 3437 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
| DA175002 | amygdala | .b | 142 to 694 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| DA334840 | hippocampus | .b | 142 to 734 | 2 to 594 | capped | 593/593 (100 %) | 0 diff (100 %id) | ||
| DA340031 | hippocampus | .b | 142 to 646 | 2 to 505 | capped | 504/504 (100 %) | 1 diff (99.9 %id) | ||
| BX104072 | uterus | .b | 3610 to 4285 | 1 to 676 | 676/676 (100 %) | 1 diff (99.9 %id) | |||
| BX431029 | brain, fetal brain | .i | 3 to 870 | 1 to 870 | D5A S7M D8M G10D C11A ... | tiling clone, | 870/932 (93 %) | 35 diff (96.3 %id) | |
| BX648348 | human uterus endothel primary cell culture | .c | 1 to 4196 | 1 to 4197 | I752V L902H | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 4197/4197 (100 %) | 4 diff (100.0 %id) |
| Z40785 | brain, total brain | .b | 4288 to 4516 | 229 to 1 | 229/229 (100 %) | 2 diff (99.2 %id) | |||
| Z45053 | brain, total brain | .b | 3332 to 3646 | 16 to 331 | 316/331 (95 %) | 9 diff (97.3 %id) | |||
| F09182 | brain, total brain | .b | 4198 to 4516 | 319 to 1 | 319/319 (100 %) | 1 diff (99.7 %id) | |||
| F11521 | brain, total brain | .b | 2973 to 3300 | 1 to 328 | 328/328 (100 %) | 0 diff (100 %id) | |||
| F09183 | brain, total brain | .b | 4196 to 4516 | 321 to 1 | 321/321 (100 %) | 1 diff (99.7 %id) | |||
| F11522 | brain, total brain | .b | 2973 to 3273 | 1 to 301 | 301/301 (100 %) | 0 diff (100 %id) | |||
| Z43112 | brain, total brain | .b | 2991 to 3319 | 1 to 329 | 329/329 (100 %) | 1 diff (99.7 %id) | |||
| CN291866 | embryonic stem cells, DMSO-treated H9 cellline | .c | 3451 to 3820 | 1 to 371 | 371/371 (100 %) | 2 diff (99.5 %id) | |||
| CN412651 | embryonic stem cells, cell lines H1, H7, andH9 | .p-u | 31 to 815 | 1 to 785 | exact | tiling clone, | 785/785 (100 %) | 3 diff (99.7 %id) | |
| CN421470 | embryonic stem cells, DMSO-treated H9 cellline | .m | 1 to 475 | 1 to 475 | tiling clone, | 475/475 (100 %) | 5 diff (99.0 %id) | ||
| CN421471 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 165 to 673 | 1 to 509 | 509/509 (100 %) | 6 diff (98.9 %id) | |||
| CN421472 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 2701 to 3316 | 1 to 617 | 617/617 (100 %) | 2 diff (99.7 %id) | |||
| CN421473 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 2701 to 3419 | 1 to 719 | 719/719 (100 %) | 1 diff (99.9 %id) | |||
| CN421474 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .m | 222 to 676 | 1 to 454 | 454/701 (64 %) | 2 diff (99.8 %id) | |||
| CN421475 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 1802 to 2378 | 31 to 607 | 577/607 (95 %) | 6 diff (99.1 %id) | |||
| CN421476 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 167 to 938 | 1 to 772 | 772/772 (100 %) | 0 diff (100 %id) | |||
| CN421477 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 1579 to 2257 | 1 to 679 | 679/679 (100 %) | 4 diff (99.5 %id) | |||
| CN421478 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 1920 to 2232 | 164 to 476 | 313/476 (65 %) | 6 diff (98.8 %id) | |||
| CN421479 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 148 to 719 | 1 to 572 | 572/572 (100 %) | 1 diff (99.9 %id) | |||
| BX431028 | brain, fetal brain | .i | 1 to 580 | 1 to 581 | tiling clone, | 581/750 (77 %) | 22 diff (97.1 %id) | ||
| AL583398 | B cells from Burkitt lymphoma | .d | 151 to 1242 | 1 to 1099 | tiling clone, | 1097/1111 (98 %) | 95 diff (91.5 %id) | ||
| BX391054 | .k | 1 to 946 | 1 to 944 | A113X C114L N115H N121K Q122S ... | tiling clone, | 944/944 (100 %) | 14 diff (98.6 %id) | ||
| CV029805 | mixed | .b | 2159 to 2789 | 1 to 631 | 631/640 (98 %) | 4 diff (99.4 %id) | |||
| BX642070 | .a | 493 to 1042 | 9 to 558 | tiling clone, | 550/558 (98 %) | 6 diff (99.0 %id) | |||
| BX642071 | .a | 3867 to 4599 | 732 to 1 | tiling clone, | 732/732 (100 %) | 3 diff (99.6 %id) | |||
| BX957136 | .b | 137 to 772 | 1 to 636 | 636/636 (100 %) | 2 diff (99.7 %id) | ||||
| BX956640 | .b | 167 to 640 | 1 to 474 | 474/474 (100 %) | 0 diff (100 %id) | ||||
| BX492822 | .b | 171 to 686 | 1 to 516 | 516/516 (100 %) | 1 diff (99.9 %id) | ||||
| BX955287 | .b | 191 to 908 | 1 to 718 | 718/718 (100 %) | 1 diff (99.9 %id) | ||||
| DA502746 | brain | .b | 135 to 688 | 2 to 555 | capped | 554/554 (100 %) | 1 diff (99.9 %id) | ||
| DB315949 | brain | .b | 3125 to 3663 | 539 to 1 | 539/539 (100 %) | 0 diff (100 %id) | |||
| DA507600 | brain | .l | 553 to 1099 | 2 to 548 | tiling clone, capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
| FN117727 | breast carcinoma | .b | 3692 to 3800 | 1 to 111 | 111/111 (100 %) | 2 diff (98.2 %id) | |||
| FN139656 | breast carcinoma | .b | 4323 to 4388 | 64 to 1 | Submitted on the opposite strand | 64/65 (98 %) | 2 diff (97.0 %id) | ||
| FN154083 | breast carcinoma | .b | 3976 to 4073 | 12 to 112 | 101/112 (90 %) | 6 diff (94.7 %id) | |||
| DB448174 | testis | .b | 347 to 416 | 361 to 430 | 430/430 (100 %) | 2 diff (99.6 %id) | |||
| DB513328 | testis | .b | 3518 to 3952 | 1 to 436 | Submitted on the opposite strand | 436/436 (100 %) | 3 diff (99.4 %id) | ||
| DB455971 | testis | .b | 347 to 446 | 395 to 494 | 494/494 (100 %) | 1 diff (99.8 %id) | |||
| DB521390 | testis | .b | 3502 to 3956 | 1 to 456 | Submitted on the opposite strand | 456/456 (100 %) | 6 diff (98.7 %id) | ||
| DB459815 | testis | .b | -11 to 435 | 1 to 447 | tiling clone, | 447/447 (100 %) | 1 diff (99.8 %id) | ||
| DB525259 | testis | .j | 1544 to 1979 | 1 to 436 | tiling clone, | Submitted on the opposite strand | 436/436 (100 %) | 0 diff (100 %id) | |
| AW069820 | bone marrow stroma | .j | 2056 to 2532 | 494 to 18 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 477/477 (100 %) | 0 diff (100 %id) | |
| R13184 | whole brain | .b | 3257 to 3523 | 1 to 269 | 269/392 (68 %) | 9 diff (97.8 %id) | |||
| R14617 | whole brain | .b | 3324 to 3682 | 6 to 376 | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 371/452 (82 %) | 24 diff (94.7 %id) | ||
| R45606 | whole brain | .b | 4178 to 4516 | 378 to 25 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 354/359 (98 %) | 18 diff (95.0 %id) | |
| R55359 | whole brain | .b | 4138 to 4516 | 412 to 24 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 389/436 (89 %) | 16 diff (96.4 %id) | |
| R55597 | whole brain | .b | 3332 to 3811 | 15 to 503 | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 489/505 (96 %) | 28 diff (94.5 %id) | ||
| R60117 | whole brain | .b | 3337 to 3872 | 1 to 543 | 543/551 (98 %) | 28 diff (95.0 %id) | |||
| T52121 | fetal spleen, Spleen | .j | 2315 to 2533 | 1 to 219 | 219/219 (100 %) | 0 diff (100 %id) | |||
| H03129 | placenta | .b | 3943 to 4380 | 1 to 445 | 445/445 (100 %) | 11 diff (97.6 %id) | |||
| W25115 | lung | .m | 197 to 585 | 1 to 390 | 390/448 (87 %) | 6 diff (98.7 %id) | |||
| W87631 | liver and spleen | .b | 3672 to 4157 | 2 to 501 | fully sequenced, | 500/501 (99 %) | 17 diff (96.7 %id) | ||
| W87632 | liver and spleen | .b | 4127 to 4516 | 395 to 1 | fully sequenced, | 395/395 (100 %) | 7 diff (98.3 %id) | ||
| AA203377 | liver and spleen | .b | 3030 to 3676 | 1 to 639 | 639/894 (71 %) | 10 diff (98.9 %id) | |||
| AA700212 | liver and spleen | .j | 2318 to 2532 | 215 to 1 | 215/215 (100 %) | 0 diff (100 %id) | |||
| AA046262 | uterus | .b | 4208 to 4524 | 322 to 1 | 322/324 (99 %) | 6 diff (98.2 %id) | |||
| AA046340 | uterus | .b | 3640 to 3855 | 1 to 216 | 216/218 (99 %) | 4 diff (98.2 %id) | |||
| AA196633 | .j | 2086 to 2540 | 464 to 10 | 455/465 (97 %) | 0 diff (100 %id) | ||||
| AA282087 | germinal center B cell | .j | 2104 to 2532 | 442 to 14 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 429/429 (100 %) | 0 diff (100 %id) | |
| AA411700 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 1988 to 2456 | 1 to 468 | 468/468 (100 %) | 1 diff (99.8 %id) | |||
| AA501413 | alveolar rhabdomyosarcoma | .j | 2261 to 2540 | 284 to 5 | 280/285 (98 %) | 0 diff (100 %id) | |||
| AA525049 | .h | 847 to 1103 | 267 to 8 | 260/267 (97 %) | 0 diff (100 %id) | ||||
| AA635514 | normal prostate, Prostate | .j | 2214 to 2532 | 319 to 1 | 319/319 (100 %) | 0 diff (100 %id) | |||
| AA744486 | germinal center B cell | .l | 1 to 337 | 343 to 7 | tiling clone, | 337/343 (98 %) | 0 diff (100 %id) | ||
| AA805086 | germinal center B cell | .j | 2126 to 2532 | 431 to 25 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 407/407 (100 %) | 1 diff (99.8 %id) | |
| AA806179 | germinal center B cell | .j | 2083 to 2532 | 474 to 25 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 450/450 (100 %) | 0 diff (100 %id) | |
| AA906055 | pooled | .j | 2158 to 2539 | 384 to 3 | 382/384 (99 %) | 0 diff (100 %id) | |||
| AA913057 | pooled | .j | 2127 to 2536 | 412 to 3 | 410/412 (99 %) | 0 diff (100 %id) | |||
| AA913250 | pooled | .j | 2141 to 2532 | 405 to 14 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 392/392 (100 %) | 0 diff (100 %id) | |
| AA913743 | pooled | .j | 2124 to 2532 | 422 to 13 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 410/410 (100 %) | 2 diff (99.6 %id) | |
| AA923723 | pooled | .n-u | 307 to 803 | 498 to 1 | exact | tiling clone, | 498/498 (100 %) | 1 diff (99.8 %id) | |
| AA962133 | pooled germ cell tumors | .j | 2304 to 2540 | 237 to 1 | 237/244 (97 %) | 0 diff (100 %id) | |||
| AI078334 | liver and spleen | .j | 2097 to 2532 | 436 to 1 | 436/436 (100 %) | 1 diff (99.8 %id) | |||
| AI200227 | placenta | .j | 2152 to 2536 | 386 to 2 | 385/386 (99 %) | 0 diff (100 %id) | |||
| AI222978 | pooled | .j | 2192 to 2536 | 345 to 1 | 345/345 (100 %) | 0 diff (100 %id) | |||
| AI332989 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .j | 2065 to 2535 | 471 to 1 | 471/471 (100 %) | 2 diff (99.6 %id) | |||
| AI417806 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 928 to 1356 | 429 to 1 | 429/429 (100 %) | 0 diff (100 %id) | |||
| AI417817 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .l | 895 to 1356 | 462 to 1 | tiling clone, | 462/463 (99 %) | 0 diff (100 %id) | ||
| AI569590 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .j | 2119 to 2532 | 429 to 16 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 414/414 (100 %) | 0 diff (100 %id) | |
| AI917434 | pooled germ cell tumors | .j | 1925 to 2539 | 616 to 1 | 616/616 (100 %) | 2 diff (99.7 %id) | |||
| AI656419 | pooled germ cell tumors | .j | 2082 to 2532 | 462 to 12 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 451/451 (100 %) | 0 diff (100 %id) | |
| AI613452 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .p-u | 1 to 457 | 459 to 3 | tiling clone, | 457/459 (99 %) | 0 diff (100 %id) | ||
| AI634693 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .j | 2082 to 2540 | 465 to 7 | 459/465 (98 %) | 0 diff (100 %id) | |||
| AI824807 | pooled germ cell tumors | .j | 2140 to 2540 | 402 to 2 | 401/402 (99 %) | 0 diff (100 %id) | |||
| AI825785 | pooled germ cell tumors | .j | 2234 to 2532 | 319 to 21 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 299/299 (100 %) | 2 diff (99.4 %id) | |
| AI674739 | pooled | .d | 3646 to 4126 | 492 to 12 | 481/492 (97 %) | 1 diff (99.8 %id) | |||
| AI806377 | pooled | .j | 2041 to 2536 | 496 to 1 | 496/496 (100 %) | 0 diff (100 %id) | |||
| AI963607 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .j | 2026 to 2532 | 521 to 15 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 507/507 (100 %) | 0 diff (100 %id) | |
| AW085052 | pooled | .j | 2296 to 2532 | 250 to 14 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 237/237 (100 %) | 1 diff (99.6 %id) | |
| AW129775 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .j | 2020 to 2540 | 526 to 6 | 521/526 (99 %) | 0 diff (100 %id) | |||
| AW150948 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .j | 2031 to 2540 | 511 to 1 | 511/511 (100 %) | 3 diff (99.5 %id) | |||
| AW182691 | pooled | .d | 3651 to 4122 | 473 to 2 | 472/473 (99 %) | 0 diff (100 %id) | |||
| AW242877 | Kidney | .j | 1941 to 2532 | 605 to 13 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 593/593 (100 %) | 6 diff (99.0 %id) | |
| AW593780 | pooled germ cell tumors | .j | 2193 to 2540 | 353 to 2 | 352/353 (99 %) | 0 diff (100 %id) | |||
| AW407404 | lymph | .b | 2035 to 2359 | 1 to 325 | 325/325 (100 %) | 5 diff (98.5 %id) | |||
| BU429555 | lymph | .b | 2751 to 3260 | 1 to 510 | 510/510 (100 %) | 5 diff (99.1 %id) | |||
| BU429345 | lymph | .b | 621 to 890 | 27 to 296 | 270/298 (90 %) | 8 diff (97.4 %id) | |||
| BF512966 | .j | 2241 to 2532 | 311 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 293/293 (100 %) | 10 diff (96.6 %id) | ||
| AW504077 | lymph | .b | 909 to 1396 | 1 to 488 | 488/488 (100 %) | 6 diff (98.8 %id) | |||
| BF509454 | .j | 2119 to 2540 | 439 to 18 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 422/427 (98 %) | 1 diff (99.8 %id) | ||
| CF135866 | lymph | .b | 1212 to 1994 | 1 to 783 | 783/783 (100 %) | 5 diff (99.4 %id) | |||
| CF137315 | lymph | .b | 3567 to 4010 | 451 to 8 | Submitted on the opposite strand | 444/451 (98 %) | 0 diff (100 %id) | ||
| BE466096 | pooled germ cell tumors | .j | 1963 to 2540 | 581 to 4 | tiling clone, | 578/581 (99 %) | 0 diff (100 %id) | ||
| BE550390 | pooled germ cell tumors | .b | 3534 to 3965 | 444 to 13 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 432/432 (100 %) | 1 diff (99.8 %id) | |
| BF061909 | pooled germ cell tumors | .b | 3278 to 3965 | 704 to 16 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 689/689 (100 %) | 2 diff (99.8 %id) | |
| BF223246 | pooled germ cell tumors | .j | 1977 to 2539 | 563 to 1 | 563/563 (100 %) | 0 diff (100 %id) | |||
| BE882106 | leiomyosarcoma, uterus | .b | 3771 to 4520 | 1 to 741 | 741/804 (92 %) | 11 diff (98.7 %id) | |||
| BF213923 | bone marrow, from acute myelogenous leukemia | .j | 1 to 631 | 1 to 635 | tiling clone, | 635/858 (74 %) | 28 diff (96.8 %id) | ||
| BI850932 | pooled germ cell tumors | .j | 1998 to 2532 | 535 to 1 | 535/541 (98 %) | 3 diff (99.5 %id) | |||
| BC029650 | Skin, normal | .m | 212 to 1591 | 1 to 1380 | exact | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 1380/1380 (100 %) | 0 diff (100 %id) |
| BG739889 | skin | .m | 212 to 1034 | 1 to 821 | A137C A138R G139R S140Q A141L ... | available from MGC, | 821/823 (99 %) | 11 diff (98.7 %id) | |
| BG772193 | testis | .e | 347 to 667 | 403 to 723 | 723/723 (100 %) | 12 diff (98.4 %id) | |||
| BC028715 | testis | .d | 347 to 4126 | 386 to 4165 | M11V | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 4165/4165 (100 %) | 3 diff (100.0 %id) |
| BG773318 | testis | .b | 347 to 537 | 398 to 591 | available from MGC, | 591/595 (99 %) | 29 diff (95.2 %id) | ||
| BI463359 | testis | .e | 347 to 711 | 375 to 738 | 738/738 (100 %) | 14 diff (98.2 %id) | |||
| BM465202 | eye, retinoblastoma | .b | 740 to 1417 | 115 to 797 | 683/1123 (60 %) | 20 diff (98.3 %id) | |||
| BQ072455 | pooled lung and spleen | .b | 3387 to 4310 | 1 to 930 | 930/991 (93 %) | 13 diff (98.7 %id) | |||
| BM995419 | Chondrosarcoma, Left Pubic Bone | .j | 1943 to 2532 | 608 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 590/590 (100 %) | 0 diff (100 %id) | |
| BM990515 | lung, Metastatic Chondrosarcoma | .j | 1943 to 2532 | 607 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 589/589 (100 %) | 3 diff (99.5 %id) | |
| BQ214943 | large cell carcinoma, lung | .b | 3618 to 4317 | 1 to 702 | 702/949 (73 %) | 7 diff (99.3 %id) | |||
| BQ440845 | leiomyosarcoma, uterus | .b | 2725 to 3613 | 1 to 893 | 893/901 (99 %) | 16 diff (98.3 %id) | |||
| CX166513 | human embryonic stem cells differentiated toan early endodermal cell type | .o | 1 to 851 | 1 to 851 | exact | tiling clone, | 851/851 (100 %) | 1 diff (99.9 %id) | |
| CX761247 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .m | 187 to 887 | 1 to 701 | Submitted on the opposite strand | 701/701 (100 %) | 3 diff (99.6 %id) | ||
| CX752031 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 3711 to 4511 | 794 to 1 | 794/794 (100 %) | 11 diff (98.7 %id) | |||
| DR760365 | embryonic stem | .j | 485 to 1293 | 1 to 808 | tiling clone, | 808/808 (100 %) | 6 diff (99.3 %id) | ||
| BC107896 | Skin and meninges pool- skin, dura matter,pia matter, choroid plexus. | .b | 1793 to 4515 | 1 to 2724 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 2724/2725 (99 %) | 5 diff (99.9 %id) | |
| CD000867 | Pooled-Skin | .b | 1794 to 2576 | 1 to 793 | 791/794 (99 %) | 29 diff (96.4 %id) | |||
| CD652230 | Embryonic Stem cells | .b | 181 to 867 | 12 to 693 | 682/805 (84 %) | 17 diff (97.9 %id) | |||
| CF993684 | Human Placenta, placenta | .b | 140 to 876 | 27 to 768 | 742/821 (90 %) | 13 diff (98.5 %id) | |||
| BC105929 | PCR rescued clones | .f | 1 to 4123 | 1 to 4123 | exact | tiling clone, | 4123/4123 (100 %) | 0 diff (100 %id) | |
| DA608072 | .b | 153 to 710 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | |||
| DA619871 | .b | 142 to 714 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | |||
| DA645361 | .b | 2111 to 2693 | 2 to 584 | capped | 583/583 (100 %) | 1 diff (99.9 %id) | |||
| NM_015608.2 | .b | 347 to 4524 | 402 to 4579 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 4579/4579 (100 %) | 0 diff (100 %id) | |
| DA794717 | brain | .b | 184 to 743 | 2 to 561 | capped | 560/560 (100 %) | 2 diff (99.7 %id) | ||
| DA802800 | brain | .b | 162 to 599 | 2 to 439 | capped | 438/438 (100 %) | 0 diff (100 %id) | ||
| DA805485 | brain | .b | 133 to 697 | 2 to 566 | capped | 565/565 (100 %) | 1 diff (99.9 %id) | ||
| DA851187 | placenta | .f | 1018 to 1587 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| BP320280 | placenta | .j | 1004 to 1600 | 1 to 598 | tiling clone, | 598/598 (100 %) | 2 diff (99.7 %id) | ||
| T25969 | .j | 2270 to 2476 | 207 to 1 | 207/247 (83 %) | 7 diff (97.2 %id) | ||||
| DN994991 | brain, whole brain | .b | 1422 to 2046 | 1 to 624 | 624/628 (99 %) | 7 diff (98.9 %id) | |||
| DR001335 | fetal brain | .b | 141 to 894 | 1 to 754 | 754/754 (100 %) | 7 diff (99.1 %id) | |||
| DB020760 | testis | .b | 1440 to 1984 | 2 to 548 | capped | 547/547 (100 %) | 4 diff (99.3 %id) | ||
| DB060760 | testis | .b | 142 to 710 | 2 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | ||
| DB064499 | testis | .b | 347 to 551 | 371 to 575 | capped | 574/574 (100 %) | 1 diff (99.9 %id) | ||
| DB065789 | testis | .b | 1 to 555 | 2 to 557 | capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
| DB065810 | testis | .b | 2519 to 3101 | 2 to 584 | capped | 583/583 (100 %) | 3 diff (99.5 %id) | ||
| DB068374 | testis | .b | 141 to 687 | 2 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
| DB068938 | testis | .b | 808 to 1366 | 2 to 560 | capped | 559/559 (100 %) | 1 diff (99.9 %id) | ||
| DB069370 | testis | .b | 347 to 506 | 370 to 529 | capped | 528/528 (100 %) | 0 diff (100 %id) | ||
| DB076141 | testis | .b | 141 to 599 | 2 to 460 | capped | 459/459 (100 %) | 0 diff (100 %id) | ||
| DB082988 | testis | .b | 133 to 691 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | ||
| DB091844 | testis | .b | 347 to 526 | 373 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | ||
| DB094967 | testis | .b | 347 to 575 | 370 to 598 | capped | 597/597 (100 %) | 1 diff (99.9 %id) | ||
| DB096844 | testis | .f | 814 to 1359 | 2 to 547 | capped | 546/546 (100 %) | 0 diff (100 %id) | ||
| DB097525 | testis | .b | 347 to 573 | 363 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
| DB100120 | testis | .b | 347 to 540 | 390 to 583 | capped | 582/582 (100 %) | 1 diff (99.9 %id) | ||
| DB143763 | thymus | .b | 2225 to 2759 | 2 to 536 | capped | 535/535 (100 %) | 0 diff (100 %id) | ||
| TI_149287490 | .b | 3694 to 4524 | 897 to 73 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 825/1114 (74 %) | 22 diff (98.1 %id) | ||
| TI_154131712 | .b | 3536 to 4516 | 1072 to 97 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 976/1000 (97 %) | 20 diff (98.0 %id) | ||
| TI_154137092 | .j | 1991 to 2532 | 620 to 78 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 543/853 (63 %) | 32 diff (96.3 %id) | ||
| TI_154145553 | .b | 2041 to 2704 | 76 to 752 | 676/843 (80 %) | 45 diff (94.7 %id) | ||||
| TI_154146705 | .b | 2041 to 2635 | 81 to 675 | 595/595 (100 %) | 4 diff (99.4 %id) | ||||
| TI_154149072 | .b | 2757 to 3261 | 112 to 621 | 510/740 (68 %) | 23 diff (96.9 %id) | ||||
| TI_154150683 | .b | 2758 to 3526 | 80 to 842 | 763/796 (95 %) | 24 diff (97.0 %id) | ||||
| TI_154160130 | .b | 916 to 1464 | 84 to 631 | 548/549 (99 %) | 11 diff (98.0 %id) | ||||
| TI_154164502 | .b | 1219 to 2116 | 77 to 974 | 898/924 (97 %) | 6 diff (99.4 %id) | ||||
| TI_154166768 | .b | 3547 to 4010 | 544 to 81 | Submitted on the opposite strand | 464/464 (100 %) | 0 diff (100 %id) | |||
| TI_157614322 | .j | 2015 to 2532 | 607 to 90 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 518/518 (100 %) | 7 diff (98.7 %id) | ||
| DB216263 | trachea | .b | 135 to 540 | 95 to 500 | capped | 406/499 (81 %) | 6 diff (98.8 %id) | ||
| BQ024660 | placenta | .j | 2063 to 2532 | 488 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 470/470 (100 %) | 0 diff (100 %id) | |
| CF528397 | placenta | .j | 2194 to 2532 | 356 to 18 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 339/339 (100 %) | 1 diff (99.8 %id) | |
| BM972796 | lung | .j | 1940 to 2540 | 619 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 601/601 (100 %) | 1 diff (99.9 %id) | |
| CA312204 | Human Lung Epithelial cells, lung | .b | 3809 to 4516 | 727 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 709/709 (100 %) | 1 diff (99.9 %id) | |
| CA503040 | Human Lung Epithelial cells, lung | .j | 2219 to 2532 | 332 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 314/323 (97 %) | 0 diff (100 %id) | |
| BM673102 | eye, optic nerve | .n-u | 1171 to 1570 | 414 to 15 | tiling clone, | 400/414 (96 %) | 0 diff (100 %id) | ||
| BM686900 | eye, optic nerve | .n-u | 1 to 553 | 9 to 561 | exact | tiling clone, | 553/563 (98 %) | 2 diff (99.7 %id) | |
| BM672694 | eye, eye anterior segment | .g | 1286 to 1873 | 603 to 15 | tiling clone, | 589/603 (97 %) | 0 diff (100 %id) | ||
| BM686291 | eye, eye anterior segment | .g | 1 to 642 | 9 to 650 | tiling clone, | 642/651 (98 %) | 6 diff (99.1 %id) | ||
| CA418184 | Bone, Human Chondrosarcoma Cell Line | .b | 3781 to 4516 | 754 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 736/736 (100 %) | 1 diff (99.9 %id) | |
| BU618427 | Cell Line, Chondrosarcoma | .b | 3787 to 4516 | 749 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 731/731 (100 %) | 3 diff (99.6 %id) | |
| CA429481 | Cell Line, Chondrosarcoma | .j | 2243 to 2532 | 308 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 290/290 (100 %) | 2 diff (99.4 %id) | |
| CA430249 | cell lines, Chondrosarcoma | .b | 2246 to 2954 | 720 to 12 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 709/720 (98 %) | 4 diff (99.5 %id) | |
| CA306504 | Alveolar Macrophage, lung | .j | 2265 to 2532 | 286 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 268/268 (100 %) | 0 diff (100 %id) | |
| DB289058 | uterus | .b | 142 to 709 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
| DB289548 | uterus | .b | 162 to 744 | 2 to 584 | capped | 583/583 (100 %) | 0 diff (100 %id) | ||
| DB290687 | uterus | .b | 135 to 716 | 2 to 583 | capped | 582/582 (100 %) | 0 diff (100 %id) | ||
| W86526 | liver and spleen | .b | 347 to 573 | 363 to 589 | This clone was ignored | 588/588 (100 %) | 1 diff (99.9 %id) | ||
| W86651 | liver and spleen | .b | 347 to 540 | 390 to 583 | This clone was ignored | 582/582 (100 %) | 1 diff (99.9 %id) | ||
| BC016903 | Uterus, leiomyosarcoma | .b | 2225 to 2759 | 2 to 536 | available from MGC, AAA | This clone was ignored | 535/535 (100 %) | 0 diff (100 %id) | |
| BE889107 | leiomyosarcoma, uterus | .b | 3694 to 4524 | 897 to 73 | available from MGC, | This clone was ignored | 825/1114 (74 %) | 22 diff (98.1 %id) | |
| DB097056 | testis | .b | 3536 to 4516 | 1072 to 97 | capped | Suspected internal deletion, this clone was ignored | 976/1000 (97 %) | 20 diff (98.0 %id) | |
| TI_154137092 | .j | 1991 to 2532 | 620 to 78 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 543/853 (63 %) | 32 diff (96.3 %id) | ||
| TI_154145553 | .b | 2041 to 2704 | 76 to 752 | 676/843 (80 %) | 45 diff (94.7 %id) | ||||
| TI_154146705 | .b | 2041 to 2635 | 81 to 675 | 595/595 (100 %) | 4 diff (99.4 %id) | ||||
| TI_154149072 | .b | 2757 to 3261 | 112 to 621 | 510/740 (68 %) | 23 diff (96.9 %id) | ||||
| TI_154150683 | .b | 2758 to 3526 | 80 to 842 | 763/796 (95 %) | 24 diff (97.0 %id) | ||||
| TI_154160130 | .b | 916 to 1464 | 84 to 631 | 548/549 (99 %) | 11 diff (98.0 %id) | ||||
| TI_154164502 | .b | 1219 to 2116 | 77 to 974 | 898/924 (97 %) | 6 diff (99.4 %id) | ||||
| TI_154166768 | .b | 3547 to 4010 | 544 to 81 | Submitted on the opposite strand | 464/464 (100 %) | 0 diff (100 %id) | |||
| TI_157614322 | .j | 2015 to 2532 | 607 to 90 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 518/518 (100 %) | 7 diff (98.7 %id) | ||
| DB216263 | trachea | .b | 135 to 540 | 95 to 500 | capped | 406/499 (81 %) | 6 diff (98.8 %id) | ||
| BQ024660 | placenta | .j | 2063 to 2532 | 488 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 470/470 (100 %) | 0 diff (100 %id) | |
| CF528397 | placenta | .j | 2194 to 2532 | 356 to 18 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 339/339 (100 %) | 1 diff (99.8 %id) | |
| BM972796 | lung | .j | 1940 to 2540 | 619 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 601/601 (100 %) | 1 diff (99.9 %id) | |
| CA312204 | Human Lung Epithelial cells, lung | .b | 3809 to 4516 | 727 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 709/709 (100 %) | 1 diff (99.9 %id) | |
| CA312204 | Human Lung Epithelial cells, lung | .b | 3809 to 4516 | 727 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 709/709 (100 %) | 1 diff (99.9 %id) | |
| CA503040 | Human Lung Epithelial cells, lung | .j | 2219 to 2532 | 332 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 314/323 (97 %) | 0 diff (100 %id) | |
| CA503040 | Human Lung Epithelial cells, lung | .j | 2219 to 2532 | 332 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 314/323 (97 %) | 0 diff (100 %id) | |
| BM673102 | eye, optic nerve | .n-u | 1171 to 1570 | 414 to 15 | tiling clone, | 400/414 (96 %) | 0 diff (100 %id) | ||
| BM673102 | eye, optic nerve | .n-u | 1171 to 1570 | 414 to 15 | tiling clone, | 400/414 (96 %) | 0 diff (100 %id) | ||
| BM686900 | eye, optic nerve | .n-u | 1 to 553 | 9 to 561 | exact | tiling clone, | 553/563 (98 %) | 2 diff (99.7 %id) | |
| BM686900 | eye, optic nerve | .n-u | 1 to 553 | 9 to 561 | exact | tiling clone, | 553/563 (98 %) | 2 diff (99.7 %id) | |
| BM672694 | eye, eye anterior segment | .g | 1286 to 1873 | 603 to 15 | tiling clone, | 589/603 (97 %) | 0 diff (100 %id) | ||
| BM672694 | eye, eye anterior segment | .g | 1286 to 1873 | 603 to 15 | tiling clone, | 589/603 (97 %) | 0 diff (100 %id) | ||
| BM686291 | eye, eye anterior segment | .g | 1 to 642 | 9 to 650 | tiling clone, | 642/651 (98 %) | 6 diff (99.1 %id) | ||
| BM686291 | eye, eye anterior segment | .g | 1 to 642 | 9 to 650 | tiling clone, | 642/651 (98 %) | 6 diff (99.1 %id) | ||
| CA418184 | Bone, Human Chondrosarcoma Cell Line | .b | 3781 to 4516 | 754 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 736/736 (100 %) | 1 diff (99.9 %id) | |
| CA418184 | Bone, Human Chondrosarcoma Cell Line | .b | 3781 to 4516 | 754 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 736/736 (100 %) | 1 diff (99.9 %id) | |
| BU618427 | Cell Line, Chondrosarcoma | .b | 3787 to 4516 | 749 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 731/731 (100 %) | 3 diff (99.6 %id) | |
| BU618427 | Cell Line, Chondrosarcoma | .b | 3787 to 4516 | 749 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 731/731 (100 %) | 3 diff (99.6 %id) | |
| CA429481 | Cell Line, Chondrosarcoma | .j | 2243 to 2532 | 308 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 290/290 (100 %) | 2 diff (99.4 %id) | |
| CA429481 | Cell Line, Chondrosarcoma | .j | 2243 to 2532 | 308 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 290/290 (100 %) | 2 diff (99.4 %id) | |
| CA430249 | cell lines, Chondrosarcoma | .b | 2246 to 2954 | 720 to 12 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 709/720 (98 %) | 4 diff (99.5 %id) | |
| CA430249 | cell lines, Chondrosarcoma | .b | 2246 to 2954 | 720 to 12 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 709/720 (98 %) | 4 diff (99.5 %id) | |
| CA306504 | Alveolar Macrophage, lung | .j | 2265 to 2532 | 286 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 268/268 (100 %) | 0 diff (100 %id) | |
| CA306504 | Alveolar Macrophage, lung | .j | 2265 to 2532 | 286 to 19 | AAA | Possibly primed on the genome, locally A rich (13/15 A in genome downstream of last aligned base) | 268/268 (100 %) | 0 diff (100 %id) | |
| DB289058 | uterus | .b | 142 to 709 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
| DB289548 | uterus | .b | 162 to 744 | 2 to 584 | capped | 583/583 (100 %) | 0 diff (100 %id) | ||
| DB290687 | uterus | .b | 135 to 716 | 2 to 583 | capped | 582/582 (100 %) | 0 diff (100 %id) |